Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Microglia (active)
[{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b408/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b408/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b407/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b407/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b406/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b406/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b405/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b405/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b404/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b404/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b403/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b403/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b402/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b402/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b401/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b401/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b400/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b400/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3ff/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3ff/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3fe/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3fe/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3fd/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3fd/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3fc/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3fc/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3fb/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3fb/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3fa/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3fa/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f9/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f9/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f8/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f8/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f7/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f7/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f6/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f6/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f5/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f5/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f4/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f4/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f3/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f3/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f2/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f2/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f1/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f1/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3f0/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3f0/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3ef/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3ef/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3ee/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3ee/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3ed/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3ed/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3ec/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3ec/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3eb/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3eb/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3ea/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3ea/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e9/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e9/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e8/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e8/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e7/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e7/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e6/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e6/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e5/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e5/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e4/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e4/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e3/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e3/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e2/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e2/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e1/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e1/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3e0/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3e0/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3df/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3df/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3de/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3de/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3dd/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3dd/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3dc/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3dc/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3db/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3db/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3da/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3da/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3d9/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3d9/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3d8/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3d8/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3d7/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3d7/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3d6/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3d6/60e36a139b713c0026b261ce.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f131750572002977b3d5/60e36a139b713c0026b261ce.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f131750572002977b3d5/60e36a139b713c0026b261ce.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
microglia,neuroglia,glial cell,neuron,macrophage,active,reactive,activated,branching,process,brain,spinal cord,active immune defense,immune defense,immune,central nervous system,cns,plastic,brain maintenance,scavenge,survey,potassium,brain function,neuroprotective,phagocytic,popular neuroscience icons,microglia
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
